He-Ping Hu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- Wnt/β-catenin signaling in development and cancer 3
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Co-authors
- Huabang Zhou (10 shared papers)Shan–Shan Zou (4 shared papers)Xiaolan Jiang (3 shared papers)Jingyi Hu (3 shared papers)Hui Wang (2 shared papers)Yuqiong Li (2 shared papers)Jeffrey Chu (1 shared paper)Qiaomei Li (1 shared paper)
- Journals
- Cancer Letters (2 papers)British Journal of Cancer (1 paper)Gene (1 paper)Molecular Genetics and Metabolism (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
He-Ping Hu
30 papers receiving 848 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 296
- Hepatology 108
- Oncology 258
- Surgery 370
- Molecular Biology 403
Countries citing papers authored by He-Ping Hu
This map shows the geographic impact of He-Ping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He-Ping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He-Ping Hu more than expected).
Fields of papers citing papers by He-Ping Hu
This network shows the impact of papers produced by He-Ping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He-Ping Hu. The network helps show where He-Ping Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside He-Ping Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 290 | |
| 2 | 2016 | 127 | |
| 3 | 2010 | 87 | |
| 4 | 2011 | 52 | |
| 5 | 2010 | 51 | |
| 6 | 2017 | 27 | |
| 7 | 2013 | 24 | |
| 8 | 2014 | 23 | |
| 9 | 2005 | 23 | |
| 10 | 2014 | 21 | |
| 11 | 2018 | 18 | |
| 12 | Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load. | 2015 | 16 |
| 13 | 2013 | 14 | |
| 14 | 2019 | 14 | |
| 15 | 2021 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2014 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2013 | 7 | |
| 20 | 2016 | 5 |
About He-Ping Hu
He-Ping Hu is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 859 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Viral-associated cancers and disorders (2 papers) and Distributed and Parallel Computing Systems (2 papers). The work is most often cited by research in Cancer Research (296 citations), Hepatology (108 citations), Oncology (258 citations), Surgery (370 citations) and Molecular Biology (403 citations). He-Ping Hu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Huabang Zhou, Shan–Shan Zou, Xiaolan Jiang, Jingyi Hu, Hui Wang, Yuqiong Li, Jeffrey Chu, Qiaomei Li, Chuan‐Fan Ding and Mengchao Wu. Their work appears in journals such as Cancer Letters, British Journal of Cancer, Gene, Molecular Genetics and Metabolism and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.